Altai Protocol Library New Reference: Osimertinib with Platinum-Pemetrexed for Advanced EGFR-Mutated NSCLC U. Darda Bayraktar, MD 2025-10-21
Altai Protocol Library New Indication: Pembrolizumab with Platinum-5FU for Advanced Penile Cancer U. Darda Bayraktar, MD 2025-10-20
Altai Protocol Library New Reference: Lenvatinib + Pembrolizumab for Melanoma U. Darda Bayraktar, MD 2025-10-20
Altai Protocol Library New Reference: Nivolumab + Cabozantinib for 1st Line RCC U. Darda Bayraktar, MD 2025-10-19
Altai Protocol Library New Reference: Adjuvant Palbociclib for HR+ Breast Cancer U. Darda Bayraktar, MD 2025-10-18
Altai Protocol Library New Reference: Abemaciclib for Adjuvant Breast Cancer U. Darda Bayraktar, MD 2025-10-18
Altai Protocol Library New Reference: Alectinib for ALK-Positive Advanced NSCLC U. Darda Bayraktar, MD 2025-10-18
Altai Protocol Library New Drug: Imlunestrant for ESR1-Mutated Advanced Breast Cancer U. Darda Bayraktar, MD 2025-10-17
Altai Protocol Library New Indication: Amivantamab-Lazertinib for First Line Advanced EGFR-Mutated NSCLC U. Darda Bayraktar, MD 2025-10-13
Multiple Myeloma New Protocol: Belantamab Mafodotin with Bortezomib/Dexamethasone for R/R Myeloma Ulas D. Bayraktar, MD 2025-09-08
